The US Department of Agriculture orders Santa Cruz Biotechnology to pay a $3.5 million fine and to cease selling research antibodies.
May 1, 2016|
Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?